Clinical Evidence

Explore the clinical evidence shaping the probiotics market today

Filter by Wellness Area

Therapeutical Areas to Clinical Evidence (desktop)
  • All
  • Weight Management
  • Gastrointestinal health
  • Pediatric health
  • Oral health
  • Cardiometabolic health
  • Immune health
  • Cognitive health
  • Skin health
  • Women's health
Therapeutical Areas to Clinical Evidence (mobile)

Filter by Product

Products to Clinical Evidence (desktop)
  • All
  • LipiGO®
  • KABP® UroSupport
  • KABP® DENTISANI
  • KABP® DENTALAC
  • KABP® Vaginal Restore
  • KABP® Digest
  • KABP®-051
  • KABP® Brain
  • Lactobacillus <i>plantarum</i> DR7®
  • KABP® Kolicare
  • KABP® AB21®
  • KABP® Metabalance
  • KABP® Kolicare
  • <i>Latilactobacillus sakei</i> proBio65®
  • KABP® Menopause
  • KABP® Intensive G.I.
  • KABP® 50+
Products to Clinical Evidence (mobile)
  • Regular consumption of LipiGO® promotes the reduction of body weight and improves the rebound effect of obese people undergo a comprehensive weight loss program

    2020

    Valero-Perez, et al

    Read
  • Effect of a polysaccharide-rich hydrolysate from Saccharomyces cerevisiae (LipiGO®) in body weight loss: randomised, double-blind, placebo-controlled clinical trial in overweight and obese adults

    2017

    Santas J, et al

    Read
  • Polysaccharide-rich hydrolysate from Saccharomyces cerevisiae (LipiGO®) increases fatty acid and neutral sterol excretion in guinea pigs fed with hypercholesterolemic diets

    2017

    Santas J, et al

    Read